Research output

  1. Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases

    Research output: Contribution to journal › Review article › Academic › peer-review

View all (13) »

ID: 18244339